TrialClinical rheumatology2007

Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis.

Alexandra Balbir-Gurman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.